The occurrence and distribution of pharmaceutical compounds in the effluents of a major sewage treatment plant in Northern Taiwan and the receiving coastal waters

Marine Pollution Bulletin

Volumn 64, Issue 7, 2012, Pages 1435-1444

  Fang, Tien Hsi ^a   Nan, Fan Hua ^a   Chin, Tzong Shean ^b   Feng, Hui Min ^a  

^a NATIONAL TAIWAN OCEAN UNIVERSITY   (Taiwan)

^b NATIONAL CHIAYI UNIVERSITY   (Taiwan)

Author keywords

Environment risk quotient; Ocean outfall; Pharmaceutical residual; Sewage treatment plant

Indexed keywords

COASTAL MARINE ECOSYSTEMS; COASTAL SEAWATER; COASTAL WATERS; ENVIRONMENT RISK QUOTIENT; ENVIRONMENTAL RISK ASSESSMENT; HALF LIVES; MARINE ENVIRONMENT; NORTHERN TAIWAN; OCCURRENCE AND DISTRIBUTION; OCEAN OUTFALLS; PHARMACEUTICAL COMPOUNDS; PHARMACEUTICAL RESIDUES; POINT SOURCES; RE-EVALUATION; REMOVAL EFFICIENCIES; THEORETICAL CALCULATIONS;

RISK ASSESSMENT; SEAWATER;

SEWAGE TREATMENT PLANTS;

DRUG; SEA WATER;

COASTAL WATER; CONCENTRATION (COMPOSITION); DRUG; EFFLUENT; ENVIRONMENTAL RISK; MARINE ENVIRONMENT; POINT SOURCE POLLUTION; RISK ASSESSMENT; SEAWATER; SEWAGE TREATMENT; WASTEWATER;

ARTICLE; COASTAL WATERS; CONCENTRATION (PARAMETERS); EFFLUENT; ENVIRONMENTAL IMPACT ASSESSMENT; ENVIRONMENTAL PARAMETERS; ENVIRONMENTAL RISK QUOTIENT; GEOGRAPHIC DISTRIBUTION; MARINE ENVIRONMENT; SEWAGE TREATMENT PLANT; TAIWAN; WASTE COMPONENT REMOVAL; WASTE WATER;

ENVIRONMENTAL MONITORING; PHARMACEUTICAL PREPARATIONS; RISK ASSESSMENT; SEAWATER; SEWAGE; TAIWAN; WASTE DISPOSAL, FLUID; WATER POLLUTANTS, CHEMICAL; WATER POLLUTION, CHEMICAL;

TAIWAN;

EID: 84863434674     PISSN: 0025326X     EISSN: 18793363     Source Type: Journal    
DOI: 10.1016/j.marpolbul.2012.04.008     Document Type: Article

References (60)

1. Ashton D., Hilton M., Thomas K.V. Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom. Science of the Total Environment 2004, 333(1-3):167-184.
2. Barbara K.H., Dinsdale R.M., Guwy A.J. The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit during wastewater treatment and its impact on the quality of receiving water. Water Research 2009, 43:363-380.
3. Benotti M., Brownawell B.J. Distribution of pharmaceuticals in an urban estuary during both dry and wet weather conditions. Environmental Science and Technology 2007, 41:5795-5802.
4. Calamari D., Zuccato E., Castiglioni S., Bagnati R., Fanelli R. Strategic survey of therapeutic drugs in the rivers Po and Lambro in northern Italy. Environmental Science and Technology 2003, 37:1241-1246.
5. Carlsson C., Johansson A.K., Alvan G., Bergman K., Kuhler T. Are pharmaceuticals potent environmental pollutants? Part I: Environmental risk assessments of selected active pharmaceuticals ingredients. Science of the Total Environment 2006, 364:67-87.
6. Castiglioni S., Bagnati R., Fanelli R., Pomati F., Calamari D., Zuccato E. Removal of pharmaceuticals in sewage treatment plants in Italy. Environmental Science and Technology 2006, 40:357-363.
7. Chen C.T.A. Rare northward flow in the Taiwan Strait in winter: a note. Continental Shelf Research 2003, 23:387-398.
8. Chen H.Y. Occurrence of pharmaceuticals in Sin-Dian River: analytical method development and risk assessments 2008, Master thesis, National Taiwan University, Taiwan.
9. Clara M., Strenn B., Gans O., Martinez E., Kreuzinger N., Kroiss H. Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. Water Research 2005, 39:4797-4807.
10. Department of Public Sewerage System Office, 2008. Annual report of environmental quality monitoring program during the sewerage system operation, Taipei City Council, Taiwan.
11. EMEA., 2005. Guideline on the environmental risk assessment of medicinal products for human use. CPMP/SWP/4447/00 draft. European Medicines Agency.
12. EU., 1994. Assessment of potential risk to the environment posed by medicinal products for human use, excluding products containing live genetically modified organisms. EU Ad Hoc. Working Party, III/5504/94 Draft 4.
13. Fang T.H. Partitioning and behavior of different forms of phosphorus in the Tanshui Estuary and one of its tributaries, Northern Taiwan. Estuarine, Coastal and Shelf Science 2000, 50:689-701.
14. Fang T.H., Lin C.L. Dissolved and particulate trace metals and their partitioning in a hypoxic estuary: the Danshui Estuary in northern Taiwan. Estuaries 2002, 25:598-607.
15. Fang T.H., Hwang J.S., Hsiao S.H., Chen H.Y. Trace metals in seawater and copepods in the ocean outfall area off the northern Taiwan coast. Marine Environmental Research 2006, 61:224-243.
16. Fent K., Weston A.A., Caminada D. Ecotoxicology of human pharmaceuticals. Aquatic Toxicology 2006, 76:122-159.
17. Ferrari B., Paxeus N., Lo Giudice R., Pollio A., Garric J. Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac. Ecotoxicology and Environmental Safety 2003, 55:359-370.
18. Ferrari B., Mons R., Vollat B., Fraysse B., Paxeus N., Giudice R.L., Pollio A., Garric J. Environmental risk assessment of six human pharmaceuticals: are the current environmental risk assessment procedures sufficient for the protection of the aquatic environment?. Environmental Toxicology and Chemistry 2004, 23:1344-1354.
19. Flippin J.L., Huggett D., Foran C.M. Changes in the timing of reproduction following chronic exposure to ibuprofen in Japanese medaka, Oryzias latipes. Aquatic Toxicology 2007, 81:73-78.
20. Garrison A.W., Pope J.D., Allen F.R. GC/MS analysis of organic compounds in domestic wastewater. Identification and Analysis of Organic Pollutants in Water 1976, 517-556. Ann Arbor Science Publishers, Ann Arbor, (Chapter 30). C.H. Keith (Ed.).
21. Halling-Sørensen B., Lutzhoft H.C., Andersen H.R., Ingerslev F. Environmental risk assessment of antibiotics: comparison of mecillinam, trimethoprim and ciprofloxacin. Journal of Antimicrobial Chemotheraphy 2000, 46:53-58.
22. Hoeger B., Kollner B., Dietrich D.R., Hitzfeld B. Water-borne diclofenac kidney and gill integrity and selected immune parameters in brown trout (Salmo trutta f. fario). Aquatic Toxicity 2005, 75:53-64.
23. Hung C.C., Gong G.C., Chen H.Y., Hsieh H.L., Santschi P.H., Wade T.L., Sericano J.L. Relationships between pesticides and organic carbon fractions in sediments of the Danshui River estuary and adjacent coastal areas of Taiwan. Environmental Pollution 2007, 148:546-554.
24. Jiann K.T., Wen L.S. Intra-annual variability of distribution patterns and fluxes of dissolved trace metals in a subtropical estuary (Danshuei River, Taiwan). Journal of Marine Systems 2009, 75:87-99.
25. Jones O.A.H., Voulvoulis N., Lester J.N. Aquatic environmental assessment of the top 25 English prescription pharmaceuticals. Water Research 2002, 36:5013-5022.
26. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B., Buxton H.T. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. Environmental Science and Technology 2002, 36:1202-1211.
27. Kostich M.S., Lazorchak J.M. Risk to aquatic organisms posed by human pharmaceutical use. Science of the Total Environment 2008, 389:329-339.
28. Lindqvist N., Tuhkanen T., Kronberg L. Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters. Water Research 2005, 39:2219-2228.
29. Lishman L., Smyth S.A., Sarafin K., Kleywegt S., Toito J., Peart T., Lee B., Servos M., Beland M., Seto P. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada. Science of the Total Environment 2006, 367:544-558.
30. Liu Q.T., Williams H. Kinetics and degradation products for direct photolysis of β-Blockers un water. Environmental Science and Technology 2007, 41:803-810.
31. Managaki S., Murata A., Takada H., Tuten B.C., Chiem N.H. Distribution of macrolides, sulfonamides, and trimethoprim in tropical waters: ubiquitous occurrence of veterinary antibiotics in the Mekong Delta. Environmental Science and Technology 2007, 41:8004-8010.
32. Metcalfe C.D., Koenig B.G., Bennie D.T., Servos M., Ternes T.A., Hirsch R. Occurrence of neutral and acidic drugs in the effluents of Canadian sewage treatment plants. Environmental Toxicology and Chemistry 2003, 22:2872-2880.
33. Naik H., Chen C.T.A. Biogeochemical cycling in the Taiwan Strait. Estuarine, Coastal and Shelf Science 2008, 78:603-612.
34. Nakada N., Tanishima T., Shinohara H., Kiri K., Takada H. Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment. Water Research 2006, 40:3297-3303.
35. Nikolaou, A., Meric, S., Fatta, D., Occurrence patterns of pharmaceuticals in water and wastewater environments. Analytical Bioanalytical Chemistry 387, 1225-1234.
36. Oaks J.L., Gilbert M., Virani M.Z., Watsin R.T., Meteyer C.U., Rideout B.A. Diclofenac residues as the cause of vulture population decline in Pakistan. Nature 2004, 427:630-633.
37. Perez-Estrada L.A., Malato S., Gernjak W., Aguera A., Thurman E.M., Ferrer I., Fernandez-Alba A.R. Photo-fenton degradation of diclofenac: identification of main intermediates and degradation pathway. Environmental Science Technology 2005, 39:8300-8306.
38. Pereira V.J., Weinberg H.S., Linden K.G., Singer P.C. UV degradation kinetics and modeling of pharmaceutical compounds in laboratory grade and surface water via direct and indirect photolysis at 254nm. Environmental Science and Technology 2007, 41:1682-1688.
39. Richardson B.J., Lam P.K.S., Martin M. Emerging chemicals of concern: pharmaceuticals and personal care products (PPCPs) in Asia, with particular reference to Southern China. Marine Pollution Bulletin 2005, 50:913-920.
40. Santos J.L., Aparicio I., Alonso E., Callejon M. Simultaneous determination of pharmaceutically active compounds in wastewater samples by solid phase extraction and high-performance liquid chromatography with diode array and fluorescence detectors. Analytica Chimica Acta 2005, 550:116-122.
41. Santos J.L., Aparicio I., Alonso E. Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain). Environment International 2007, 33:596-601.
42. Schmidt W., O'rourke K., Hernan R., Quinn B. Effects of the pharmaceuticals gemfibrozil and diclofenac on the marine mussel (Mytilus spp.) and their comparison with standardized toxicity tests. Marine Pollution Bulletin 2011, 62:1389-1395.
43. Schwaiger J., Ferling H., Mallow U., Wintermayr H., Negele R.D. Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part I: histopathological alterations and bioaccumulation in rainbow trout. Aquatic Toxicology 2004, 68:141-150.
44. Sein M.M., Zedda M., Tuerk J., Schmidt T.C., Golloch A., von Sonntag C. Oxidation of diclofenac with ozone in aqueous solution. Environmental Science Technology 2008, 42:6656-6662.
45. Strenn B., Clara M., Gans O., Kreuzinger N. Carbamazepine, diclofenac, ibuprofen and bezafibrate-investigations on the behaviour of selected pharmaceuticals during wastewater treatment. Water Science Technology 2004, 50:269-276.
46. Stuer-Lauridsen F., Birkved M., Hansen L.P., Holten Lutzhøft H.C., Halling-Sørenson B. Environmental risk assessment of human pharmaceuticals in Denmark after normal therapeutic use. Chemosphere 2000, 40:783-793.
47. Tauxe-Wuersch A., Alencastro L.F.D., Grandjean D., Tarradellas J. Occurrence of several acidic drugs in sewage treatment plants in Switzerland and risk assessment. Water Research 2005, 39:1761-1772.
48. Ternes T. Occurrence of drugs in German sewage treatment plants and rivers. Water Research 1998, 11:3245-3260.
49. Ternes T.A., Stumpf M., Mueller J., Haberer K., Wilken R.D., Servos M. Behavior and occurrence of estrogens in municipal sewage treatment plants, Investigations in Germany, Canada and Brazil. Science of the Total Environment 1999, 225:81-90.
50. Tixier C., Singer H.P., Oellers S., Müller R. Occurrence and fate of carbamazepine, clofibric acid, diclofenac, ibuprofen, ketoprofen, and naproxen in surface waters. Environmental Science and Technology 2003, 37:1061-1068.
51. Thomas K.V., Hilton M.J. The occurrence of selected human pharmaceutical compounds in UK estuaries. Marine Pollution Bulletin 2004, 49:436-444.
52. Triebskorn R., Casper H., Heyd A., Eikemper R., Kohler H.R., Schwaiger J. Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part II. Cytological effects in liver, kidney, gills and intestine of rainbow trout (Oncorhynchus mykiss). Aquatic Toxicology 2004, 68:151-166.
53. Yu J.T., Bouwer E.J., Coelhan M. Occurrence and biodegradability studies of selected pharmaceuticals and personal care products in sewage effluent. Agriculture Water Management 2006, 86:72-80.
54. Weigel S., Kuhlmann J., Huhnerfuss H. Drugs and personal care products as ubiquitous pollutants: occurrence and distribution of clofibric acid, caffeine and DEET in the North Sea. The Science of the Total Environment 2002, 295:131-141.
55. Wiegel S., Aulinger A., Brockmeyer R., Harms H., Loffler J., Reincke H., Schmidt R., Stachel B., von Tumpling W., Wanke A. Pharmaceuticals in the river Elbe and its tributaries. Chemosphere 2004, 57:107-126.
56. Weigel S., Berger U., Jensen E., Kallenborn R., Thoresen H., Huhnerfuss H. Determination of selected pharmaceuticals and caffeine in sewage and seawater from Tromsø/Norway with emphasis on ibuprofen and its metabolites. Chemosphere 2004, 56:583-592.
57. Wu, S.C. 1997. The treatment of domestic sewage by soil. EPA report: EPA 86-E3G1-09-02, ROC (in Chinese).
58. Zhang S., Zhang Q., Darisaw S., Ehie O., Wang G. Simultaneous quantification of polycyclic aromatic hydrocarbons (PAHs), polychlorinated biphenyls (PCBs), and pharmaceuticals and personal care products (PPCPs) in Mississippi river water in New Orleans, Louisiana, USA. Chemosphere 2007, 66:1057-1069.
59. Zhang Z.L., Zhou J.L. Simultaneous determination of various pharmaceutical compounds in water by solid-phase extraction-liquid chromatography-tandem mass spectrometry. Journal of Chromatography A 2007, 1154:205-213.
60. Zwiener C., Frimmel F.H. Short-term tests with a pilot sewage plant and biofilm reactors for the biological degradation of the pharmaceutical compounds clofibric acid, ibuprofen and diclofenac. The Science of the Total Environment 2003, 309:201-211.